These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
654 related items for PubMed ID: 12789259
21. Retinoid receptors in health and disease: co-regulators and the chromatin connection. Minucci S, Pelicci PG. Semin Cell Dev Biol; 1999 Apr; 10(2):215-25. PubMed ID: 10441075 [Abstract] [Full Text] [Related]
22. The zinc finger repressor, ZBP-89, recruits histone deacetylase 1 to repress vimentin gene expression. Wu Y, Zhang X, Salmon M, Zehner ZE. Genes Cells; 2007 Aug; 12(8):905-18. PubMed ID: 17663720 [Abstract] [Full Text] [Related]
28. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha. Kinoshita Y, Chen S. Cancer Res; 2003 Jul 01; 63(13):3546-55. PubMed ID: 12839940 [Abstract] [Full Text] [Related]
29. Transcription factor decoy against promoter C of estrogen receptor alpha gene induces a functional ER alpha protein in breast cancer cells. Lambertini E, Penolazzi L, Magaldi S, Giordano S, Senno LD, Piva R. Breast Cancer Res Treat; 2005 Jul 01; 92(2):125-32. PubMed ID: 15986121 [Abstract] [Full Text] [Related]
30. Epigenetic modulation of estrogen receptor-alpha by pRb family proteins: a novel mechanism in breast cancer. Macaluso M, Montanari M, Noto PB, Gregorio V, Bronner C, Giordano A. Cancer Res; 2007 Aug 15; 67(16):7731-7. PubMed ID: 17699777 [Abstract] [Full Text] [Related]
31. Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells. Yang X, Phillips DL, Ferguson AT, Nelson WG, Herman JG, Davidson NE. Cancer Res; 2001 Oct 01; 61(19):7025-9. PubMed ID: 11585728 [Abstract] [Full Text] [Related]
32. Release of methyl CpG binding proteins and histone deacetylase 1 from the Estrogen receptor alpha (ER) promoter upon reactivation in ER-negative human breast cancer cells. Sharma D, Blum J, Yang X, Beaulieu N, Macleod AR, Davidson NE. Mol Endocrinol; 2005 Jul 01; 19(7):1740-51. PubMed ID: 15746193 [Abstract] [Full Text] [Related]
33. A mechanism of COOH-terminal binding protein-mediated repression. Meloni AR, Lai CH, Yao TP, Nevins JR. Mol Cancer Res; 2005 Oct 01; 3(10):575-83. PubMed ID: 16254191 [Abstract] [Full Text] [Related]
34. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter. Araki K, Nakajima Y, Eto K, Ikeda MA. Oncogene; 2003 Oct 23; 22(48):7632-41. PubMed ID: 14576826 [Abstract] [Full Text] [Related]
35. Interplay between the retinoblastoma related pRb2/p130 and E2F-4 and -5 in relation to JCV-TAg. Caracciolo V, Reiss K, Crozier-Fitzgerald C, De Pascali F, Macaluso M, Khalili K, Giordano A, Claudio PP. J Cell Physiol; 2007 Jul 23; 212(1):96-104. PubMed ID: 17385710 [Abstract] [Full Text] [Related]
36. In vivo complex formation of PU.1 with HDAC1 associated with PU.1-mediated transcriptional repression. Kihara-Negishi F, Yamamoto H, Suzuki M, Yamada T, Sakurai T, Tamura T, Oikawa T. Oncogene; 2001 Sep 20; 20(42):6039-47. PubMed ID: 11593411 [Abstract] [Full Text] [Related]
37. EVI1 recruits the histone methyltransferase SUV39H1 for transcription repression. Cattaneo F, Nucifora G. J Cell Biochem; 2008 Oct 01; 105(2):344-52. PubMed ID: 18655152 [Abstract] [Full Text] [Related]
38. Ciz1, a Novel DNA-binding coactivator of the estrogen receptor alpha, confers hypersensitivity to estrogen action. den Hollander P, Rayala SK, Coverley D, Kumar R. Cancer Res; 2006 Nov 15; 66(22):11021-9. PubMed ID: 17108141 [Abstract] [Full Text] [Related]
39. Role of pRB-family/E2F complex in the inhibition of IL-3-dependent lymphoid cell proliferation. Yamada M, Kondo T, Ashizawa S, Takebayashi T, Higashi H, Hatakeyama M. Cytokine; 2002 Jan 21; 17(2):91-7. PubMed ID: 11886176 [Abstract] [Full Text] [Related]